Pregnancy and Long-Term Maternal Cardiovascular Health: Progress Through Harmonization of Research Cohorts and Biobanks

Hypertension

Volumn 67, Issue 2, 2016, Pages 251-260

  Staff, Anne Cathrine ^a   Redman, Christopher W G ^b   Williams, David ^c   Leeson, Paul ^b   Moe, Kjartan ^a   Thilaganathan, Basky ^d   Magnus, Per ^e   Steegers, Eric A P ^f   Tsigas, Eleni Z ^g   Ness, Roberta B ^h   Myatt, Leslie ⁱ   Poston, Lucilla ^j   Roberts, James M ^k  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d ST GEORGE S HOSPITAL   (United Kingdom)

^e NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g Preeclampsia Foundation   (Australia)

^h UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^j KING'S COLLEGE LONDON   (United Kingdom)

^k UNIVERSITY OF PITTSBURGH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CLINICAL SUPERVISION; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; INTRAUTERINE GROWTH RETARDATION; MATERNAL WELFARE; MEDICAL RESEARCH; PATIENT MONITORING; PHYSICAL ACTIVITY; PLACENTA DISORDER; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREMATURITY; PRIORITY JOURNAL; PUERPERIUM; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SPONTANEOUS ABORTION; WEIGHT CONTROL; BIOBANK; CARDIOVASCULAR SYSTEM; EARLY DIAGNOSIS; METABOLISM; PATHOPHYSIOLOGY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROCEDURES;

BIOLOGICAL SPECIMEN BANKS; BIOMARKERS; BIOMEDICAL RESEARCH; CARDIOVASCULAR SYSTEM; EARLY DIAGNOSIS; FEMALE; HUMANS; MATERNAL HEALTH; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

EID: 84954357629     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.06357     Document Type: Review

References (106)

1. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. Circulation. 2011;123:1243-1262. doi: 10.1161/CIR.0b013e31820faaf8.
2. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening BMJ. 2002;325:157-160.
3. Rich-Edwards JW. Reproductive health as a sentinel of chronic disease in women. Womens Health (Lond Engl). 2009;5:101-105. doi: 10.2217/17455057.5.2.101.
4. Roberts JM, Hubel CA. Pregnancy: a screening test for later life cardiovascular disease. Womens Health Issues. 2010;20:304-307. doi: 10.1016/j.whi.2010.05.004.
5. Mosca L, Benjamin EJ, Berra K, et al; American Heart Association. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. J Am Coll Cardiol. 2011;57:1404-1423. doi: 10.1016/j.jacc.2011.02.005.
6. Lawton JS. Sex and gender differences in coronary artery disease. Semin Thorac Cardiovasc Surg. 2011;23:126-130. doi: 10.1053/j. semtcvs.2011.07.006.
7. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sexbased differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med. 1999;341:217-225. doi: 10.1056/NEJM199907223410401.
8. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' task force on hypertension in pregnancy. Obstet Gynecol. 2013;122:1122-1131. doi: 10.1097/01.AOG.0000437382.03963.88.
9. Redman CW, Sargent IL, Staff AC. IFPA Senior Award Lecture: making sense of pre-eclampsia-two placental causes of preeclampsia Placenta. 2014;35:S20-S25. doi: 10.1016/j.placenta.2013.12.008.
10. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ. 2001;323:1213-1217.
11. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet. 2001;357:2002-2006. doi: 10.1016/S0140-6736(00)05112-6.
12. Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, Paidas MJ. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension. 2009;53:944-951. doi: 10.1161/HYPERTENSIONAHA.109.130765.
13. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974. doi: 10.1136/bmj.39335.385301.BE.
14. Wikström AK, Haglund B, Olovsson M, Lindeberg SN. The risk of maternal ischaemic heart disease after gestational hypertensive disease. BJOG. 2005;112:1486-1491. doi: 10.1111/j.1471-0528.2005.00733.x.
15. Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol. 2006;195:40-49. doi: 10.1016/j.ajog.2005.07.049.
16. Newstead J, von Dadelszen P, Magee LA. Preeclampsia and future cardiovascular risk. Expert Rev Cardiovasc Ther. 2007;5:283-294. doi: 10.1586/14779072.5.2.283.
17. Mongraw-Chaffin ML, Cirillo PM, Cohn BA. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension. 2010;56:166-171. doi: 10.1161/HYPERTENSIONAHA.110.150078.
18. Ness RB, Hubel CA. Risk for coronary artery disease and morbid preeclampsia: a commentary. Ann Epidemiol. 2005;15:726-733. doi: 10.1016/j.annepidem.2005.02.007.
19. Harskamp RE, Zeeman GG. Preeclampsia: at risk for remote cardiovascular disease. Am J Med. Sci. 2007;334:291-295. doi: 10.1097/MAJ.0b013e3180a6f094.
20. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet. 2005;366:1797-1803. doi: 10.1016/S0140-6736(05)67726-4.
21. Lazdam M, de la Horra A, Diesch J, Kenworthy Y, Davis E, Lewandowski AJ, Szmigielski C, Shore A, Mackillop L, Kharbanda R, Alp N, Redman C, Kelly B, Leeson P. Unique blood pressure characteristics in mother and offspring after early onset preeclampsia. Hypertension. 2012;60:1338-1345. doi: 10.1161/HYPERTENSIONAHA.112.198366.
22. Veerbeek JH, Hermes W, Breimer AY, van Rijn BB, Koenen SV, Mol BW, Franx A, de Groot CJ, Koster MP. Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancyinduced hypertension. Hypertension. 2015;65:600-606. doi: 10.1161/HYPERTENSIONAHA.114.04850.
23. Robbins CL, Hutchings Y, Dietz PM, Kuklina EV, Callaghan WM. History of preterm birth and subsequent cardiovascular disease: a systematic review. Am J Obstet Gynecol. 2014;210:285-297. doi: 10.1016/j.ajog.2013.09.020.
24. Catov JM, Wu CS, Olsen J, Sutton-Tyrrell K, Li J, Nohr EA. Early or recurrent preterm birth and maternal cardiovascular disease risk. Ann Epidemiol. 2010;20:604-609. doi: 10.1016/j.annepidem.2010.05.007.
25. Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science. 2014;345:760-765. doi: 10.1126/science.1251816.
26. Bonamy AK, Parikh NI, Cnattingius S, Ludvigsson JF, Ingelsson E. Birth characteristics and subsequent risks of maternal cardiovascular disease: effects of gestational age and fetal growth. Circulation. 2011;124:2839-2846. doi: 10.1161/CIRCULATIONAHA.111.034884.
27. Oliver-Williams CT, Heydon EE, Smith GC, Wood AM. Miscarriage and future maternal cardiovascular disease: a systematic review and metaanalysis. Heart. 2013;99:1636-1644. doi: 10.1136/heartjnl-2012-303237.
28. Germain AM, Romanik MC, Guerra I, Solari S, Reyes MS, Johnson RJ, Price K, Karumanchi SA, Valdés G. Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events Hypertension. 2007;49:90-95. doi: 10.1161/01.HYP.0000251522.18094.d4.
29. Sheiner E, Levy A, Katz M, Mazor M. Pregnancy outcome following recurrent spontaneous abortions. Eur J Obstet Gynecol Reprod Biol. 2005;118:61-65. doi: 10.1016/j.ejogrb.2004.06.015.
30. Veerbeek JH, Smit JG, Koster MP, Post Uiterweer ED, van Rijn BB, Koenen SV, Franx A. Maternal cardiovascular risk profile after placental abruption. Hypertension. 2013;61:1297-1301. doi: 10.1161/HYPERTENSIONAHA.111.00930.
31. Shah BR, Retnakaran R, Booth GL. Increased risk of cardiovascular disease in young women following gestational diabetes mellitus. Diabetes Care. 2008;31:1668-1669. doi: 10.2337/dc08-0706.
32. Metzger BE, Cho NH, Roston SM, Radvany R. Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care. 1993;16:1598-1605.
33. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373:1773-1779. doi: 10.1016/S0140-6736(09)60731-5.
34. Weissgerber TL, Mudd LM. Preeclampsia and diabetes. Curr Diab Rep. 2015;15:9. doi: 10.1007/s11892-015-0579-4.
35. Briasoulis A, Bakris GL. Chronic kidney disease as a coronary artery disease risk equivalent. Curr Cardiol Rep. 2013;15:340. doi: 10.1007/s11886-012-0340-4.
36. Dekker JM, Schouten EG. Number of pregnancies and risk of cardiovascular disease. N Engl J Med. 1993;329:1893-1894; author reply 1894.
37. Green A, Beral V, Moser K. Mortality in women in relation to their childbearing history. BMJ. 1988;297:391-395.
38. Lawlor DA, Emberson JR, Ebrahim S, Whincup PH, Wannamethee SG, Walker M, Smith GD; British Women's Heart and Health Study; British Regional Heart Study. Is the association between parity and coronary heart disease due to biological effects of pregnancy or adverse lifestyle risk factors associated with child-rearing Findings from the British Women's Heart and Health Study and the British Regional Heart Study. Circulation. 2003;107:1260-1264.
39. Ness RB, Harris T, Cobb J, Flegal KM, Kelsey JL, Balanger A, Stunkard AJ, D'Agostino RB. Number of pregnancies and the subsequent risk of cardiovascular disease. N Engl J Med. 1993;328:1528-1533. doi: 10.1056/NEJM199305273282104.
40. Parikh NI, Cnattingius S, Dickman PW, Mittleman MA, Ludvigsson JF, Ingelsson E. Parity and risk of later-life maternal cardiovascular disease. Am Heart J. 2010;159:215-221.e6. doi: 10.1016/j.ahj.2009.11.017.
41. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. A prospective study of age at menarche, parity, age at first birth, and coronary heart disease in women. Am J Epidemiol. 1987;126:861-870.
42. Steenland K, Lally C, Thun M. Parity and coronary heart disease among women in the American Cancer Society CPS II population. Epidemiology. 1996;7:641-643.
43. Ness RB, Cobb J, Harris T, D'Agostino RB. Does number of children increase the rate of coronary heart disease in men Epidemiology. 1995;6:442-445.
44. Halland F, deRoo L, Morken NH, Klungsoyr K, Wilcox AJ, Skjaerven R. Association of women's reproductive history with long-term mortality and effect of socioeconomic factors. Obstet Gynecol. 2015;126:1181-1187. doi: 10.1097/AOG.0000000000001155.
45. Parikh NI, Cnattingius S, Mittleman MA, Ludvigsson JF, Ingelsson E. Subfertility and risk of later life maternal cardiovascular disease. Hum Reprod. 2012;27:568-575. doi: 10.1093/humrep/der400.
46. Rich-Edwards JW, Fraser A, Lawlor DA, Catov JM. Pregnancy characteristics and women's future cardiovascular health: an underused opportunity to improve women's health Epidemiol Rev. 2014;36:57-70. doi: 10.1093/epirev/mxt006.
47. Eskild A, Romundstad PR, Vatten LJ. Placental weight and birthweight: does the association differ between pregnancies with and without preeclampsia Am J Obstet Gynecol. 2009;201:595e1-595e5. doi: 10.1016/j.ajog.2009.06.003.
48. Risnes KR, Romundstad PR, Nilsen TI, Eskild A, Vatten LJ. Placental weight relative to birth weight and long-term cardiovascular mortality: findings from a cohort of 31,307 men and women. Am J Epidemiol. 2009;170:622-631. doi: 10.1093/aje/kwp182.
49. Schwarz EB, Ray RM, Stuebe AM, Allison MA, Ness RB, Freiberg MS, Cauley JA. Duration of lactation and risk factors for maternal cardiovascular disease. Obstet Gynecol. 2009;113:974-982. doi: 10.1097/01. AOG.0000346884.67796.ca.
50. Liu LX, Arany Z. Maternal cardiac metabolism in pregnancy. Cardiovasc Res. 2014;101:545-553. doi: 10.1093/cvr/cvu009.
51. Broere-Brown ZA, Schalekamp-Timmermans S, Hofman A, Jaddoe V, Steegers E. Fetal sex dependency of maternal vascular adaptation to pregnancy: a prospective population-based cohort study [published online ahead of print July 14, 2015]. BJOG. doi: 10.1111/1471-0528.13519. http://onlinelibrary.wiley.com/doi/10.1111/1471-0528.13519/full. Accessed December 9, 2015.
52. Parikh NI, Lloyd-Jones DM, Ning H, Ouyang P, Polak JF, Lima JA, Bluemke D, Mittleman MA. Association of number of live births with left ventricular structure and function. The Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J. 2012;163:470-476. doi: 10.1016/j.ahj.2011.12.011.
53. Martin U, Davies C, Hayavi S, Hartland A, Dunne F. Is normal pregnancy atherogenic Clin Sci (Lond). 1999;96:421-425.
54. Ness RB, Roberts JM. Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol. 1996;175:1365-1370.
55. Buurma AJ, Turner RJ, Driessen JH, Mooyaart AL, Schoones JW, Bruijn JA, Bloemenkamp KW, Dekkers OM, Baelde HJ. Genetic variants in preeclampsia: a meta-analysis. Hum Reprod Update. 2013;19:289-303. doi: 10.1093/humupd/dms060.
56. Johnson MP, Brennecke SP, East CE, et al; FINNPEC Study Group. Genetic dissection of the pre-eclampsia susceptibility locus on chromosome 2q22 reveals shared novel risk factors for cardiovascular disease. Mol Hum Reprod. 2013;19:423-437. doi: 10.1093/molehr/gat011.
57. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999;180(2 pt 1):499-506.
58. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J. 1999;138(5 pt 2):S419-S420.
59. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115-126. doi: 10.1056/NEJM199901143400207.
60. Rosing U, Samsioe G, Olund A, Johansson B, Kallner A. Serum levels of apolipoprotein A-I, A-II and HDL-cholesterol in second half of normal pregnancy and in pregnancy complicated by pre-eclampsia. Horm Metab Res. 1989;21:376-382. doi: 10.1055/s-2007-1009242.
61. Hubel CA, Lyall F, Weissfeld L, Gandley RE, Roberts JM. Small low-density lipoproteins and vascular cell adhesion molecule-1 are increased in association with hyperlipidemia in preeclampsia. Metabolism. 1998;47:1281-1288.
62. Sattar N, Bendomir A, Berry C, Shepherd J, Greer IA, Packard CJ. Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol. 1997;89:403-408. doi: 10.1016/S0029-7844(96)00514-5.
63. Wetzka B, Winkler K, Kinner M, Friedrich I, März W, Zahradnik HP. Altered lipid metabolism in preeclampsia and HELLP syndrome: links to enhanced platelet reactivity and fetal growth. Semin Thromb Hemost. 1999;25:455-462. doi: 10.1055/s-2007-994950.
64. Ware-Jauregui S, Sanchez SE, Zhang C, Laraburre G, King IB, Williams MA. Plasma lipid concentrations in pre-eclamptic and normotensive Peruvian women. Int J Gynaecol Obstet. 1999;67:147-155.
65. Staff AC, Dechend R, Pijnenborg R. Learning from the placenta: acute atherosis and vascular remodeling in preeclampsia-novel aspects for atherosclerosis and future cardiovascular health. Hypertension. 2010;56:1026-1034. doi: 10.1161/HYPERTENSIONAHA.110.157743.
66. Barden A. Pre-eclampsia: contribution of maternal constitutional factors and the consequences for cardiovascular health. Clin Exp Pharmacol Physiol. 2006;33:826-830. doi: 10.1111/j.1440-1681.2006.04448.x.
67. Wikström AK, Stephansson O, Cnattingius S. Tobacco use during pregnancy and preeclampsia risk: effects of cigarette smoking and snuff. Hypertension. 2010;55:1254-1259. doi: 10.1161/HYPERTENSIONAHA.109.147082.
68. Cudmore M, Ahmad S, Al-Ani B, Fujisawa T, Coxall H, Chudasama K, Devey LR, Wigmore SJ, Abbas A, Hewett PW, Ahmed A. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation. 2007;115:1789-1797. doi: 10.1161/CIRCULATIONAHA.106.660134.
69. Jeyabalan A, Powers RW, Durica AR, Harger GF, Roberts JM, Ness RB. Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia. Am J Hypertens. 2008;21:943-947. doi: 10.1038/ajh.2008.219.
70. Magnussen EB, Vatten LJ, Lund-Nilsen TI, Salvesen KA, Davey Smith G, Romundstad PR. Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study. BMJ. 2007;335:978. doi: 10.1136/bmj.39366.416817.BE.
71. Magnussen EB, Vatten LJ, Smith GD, Romundstad PR. Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstet Gynecol. 2009;114:961-970. doi: 10.1097/AOG.0b013e3181bb0dfc.
72. Romundstad PR, Magnussen EB, Smith GD, Vatten LJ. Hypertension in pregnancy and later cardiovascular risk: common antecedents Circulation. 2010;122:579-584. doi: 10.1161/CIRCULATIONAHA.110.943407.
73. Staff AC, Dechend R, Redman CW. Review: preeclampsia, acute atherosis of the spiral arteries and future cardiovascular disease: two new hypotheses. Placenta. 2013;34:S73-S78. doi: 10.1016/j.placenta.2012.11.022.
74. Melchiorre K, Sharma R, Thilaganathan B. Cardiovascular implications in preeclampsia: an overview. Circulation. 2014;130:703-714. doi: 10.1161/CIRCULATIONAHA.113.003664.
75. Staff AC, Benton SJ, von Dadelszen P, Roberts JM, Taylor RN, Powers RW, Charnock-Jones DS, Redman CW. Redefining preeclampsia using placenta-derived biomarkers. Hypertension. 2013;61:932-942. doi: 10.1161/HYPERTENSIONAHA.111.00250.
76. Kvehaugen AS, Dechend R, Ramstad HB, Troisi R, Fugelseth D, Staff AC. Endothelial function and circulating biomarkers are disturbed in women and children after preeclampsia. Hypertension. 2011;58:63-69. doi: 10.1161/HYPERTENSIONAHA.111.172387.
77. Wolf M, Hubel CA, Lam C, Sampson M, Ecker JL, Ness RB, Rajakumar A, Daftary A, Shakir AS, Seely EW, Roberts JM, Sukhatme VP, Karumanchi SA, Thadhani R. Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab. 2004;89:6239-6243. doi: 10.1210/jc.2004-0548.
78. Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation. 2010;122:478-487. doi: 10.1161/CIRCULATIONAHA.109.895458.
79. Saxena AR, Karumanchi SA, Brown NJ, Royle CM, McElrath TF, Seely EW. Increased sensitivity to angiotensin II is present postpartum in women with a history of hypertensive pregnancy. Hypertension. 2010;55:1239-1245. doi: 10.1161/HYPERTENSIONAHA.109.147595.
80. Hubel CA, Wallukat G, Wolf M, Herse F, Rajakumar A, Roberts JM, Markovic N, Thadhani R, Luft FC, Dechend R. Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension. 2007;49:612-617. doi: 10.1161/01.HYP.0000256565.20983.d4.
81. Bytautiene E, Bulayeva N, Bhat G, Li L, Rosenblatt KP, Saade GR. Longterm alterations in maternal plasma proteome after sFlt1-induced preeclampsia in mice. Am J Obstet Gynecol. 2013;208:388e1-388e10. doi: 10.1016/j.ajog.2013.01.042.
82. Lin C, Rajakumar A, Plymire DA, Verma V, Markovic N, Hubel CA. Maternal endothelial progenitor colony-forming units with macrophage characteristics are reduced in preeclampsia. Am J Hypertens. 2009;22:1014-1019. doi: 10.1038/ajh.2009.101.
83. Autiero M, Waltenberger J, Communi D, et al. Role of PlGF in the intraand intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med. 2003;9:936-943. doi: 10.1038/nm884.
84. Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, Carmeliet P, Young PP. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J. 2006;20:1495-1497. doi: 10.1096/fj.05-5137fje.
85. Melchiorre K, Sutherland GR, Liberati M, Thilaganathan B. Preeclampsia is associated with persistent postpartum cardiovascular impairment. Hypertension. 2011;58:709-715. doi: 10.1161/HYPERTENSIONAHA.111.176537.
86. Kane GC, Karon BL, Mahoney DW, Redfield MM, Roger VL, Burnett JC Jr, Jacobsen SJ, Rodeheffer RJ. Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA. 2011;306:856-863. doi: 10.1001/jama.2011.1201.
87. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003;289:194-202.
88. Roberts JM, Catov JM. Pregnancy is a screening test for later life cardiovascular disease: now what Research recommendations. Womens Health Issues. 2012;22:e123-e128. doi: 10.1016/j.whi.2012.01.001.
89. Pinsky JL, Branch LG, Jette AM, Haynes SG, Feinleib M, Cornoni-Huntley JC, Bailey KR. Framingham Disability Study: relationship of disability to cardiovascular risk factors among persons free of diagnosed cardiovascular disease. Am J Epidemiol. 1985;122:644-656.
90. Lenderink T, Heeschen C, Fichtlscherer S, Dimmeler S, Hamm CW, Zeiher AM, Simoons ML, Boersma E; CAPTURE Investigators. Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes. J Am Coll Cardiol. 2006;47:307-311. doi: 10.1016/j.jacc.2005.08.063.
91. National Institute for Health and Clinical Excellence. Hypertension in Pregnancy: the Management of Hypertensive Disorders During Pregnancy (Clinical Guideline 107). London: RCOG Press; 2010.
92. Myatt L, Redman CW, Staff AC, Hansson S, Wilson ML, Laivuori H, Poston L, Roberts JM; Global Pregnancy CoLaboratory. Strategy for standardization of preeclampsia research study design. Hypertension. 2014;63:1293-1301. doi: 10.1161/HYPERTENSIONAHA.113.02664.
93. Burton GJ, Sebire NJ, Myatt L, Tannetta D, Wang YL, Sadovsky Y, Staff AC, Redman CW. Optimising sample collection for placental research. Placenta. 2014;35:9-22. doi: 10.1016/j.placenta.2013.11.005.
94. Burke O, Benton S, Szafranski P, et al. [94-OR]: Extending the scope of individual patient data meta-analyses: merging algorithms for biomarker measurements from heterogeneous laboratory platforms. The CoLAB preeclampsia angiogenic factor study. Pregnancy Hypertens. 2015;5:50-51.
95. Jaddoe VW, Bakker R, van Duijn CM, van der Heijden AJ, Lindemans J, Mackenbach JP, Moll HA, Steegers EA, Tiemeier H, Uitterlinden AG, Verhulst FC, Hofman A. The Generation R Study Biobank: a resource for epidemiological studies in children and their parents. Eur J Epidemiol. 2007;22:917-923. doi: 10.1007/s10654-007-9209-z.
96. Kruithof CJ, Kooijman MN, van Duijn CM, et al. The Generation R Study: biobank update 2015. Eur J Epidemiol. 2014;29:911-927. doi: 10.1007/s10654-014-9980-6.
97. Gishti O, Jaddoe VW, Felix JF, Reiss I, Hofman A, Ikram MK, Steegers EA, Gaillard R. Influence of maternal angiogenic factors during pregnancy on microvascular structure in school-age children. Hypertension. 2015;65:722-728. doi: 10.1161/HYPERTENSIONAHA.114.05008.
98. Rønningen KS, Paltiel L, Meltzer HM, Nordhagen R, Lie KK, Hovengen R, Haugen M, Nystad W, Magnus P, Hoppin JA. The biobank of the Norwegian Mother and Child Cohort Study: a resource for the next 100 years. Eur J Epidemiol. 2006;21:619-625. doi: 10.1007/s10654-006-9041-x.
99. Magnus P, Irgens LM, Haug K, Nystad W, Skjaerven R, Stoltenberg C; MoBa Study Group. Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa). Int J Epidemiol. 2006;35:1146-1150. doi: 10.1093/ije/dyl170.
100. Harrison S, Petrovic G, Chevassut A, Brook L, Higgins N, Kenworthy Y, Selwood M, Snelgar T, Arnold L, Boardman H, Heneghan C, Leeson P, Redman C, Granne I. Oxfordshire Women and Their Children's Health (OxWATCH): protocol for a prospective cohort feasibility study. BMJ Open. 2015;5:e009282. doi: 10.1136/bmjopen-2015-009282.
101. Ala-Korpela M. Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics. Clin Chem Lab Med. 2008;46:27-42. doi: 10.1515/CCLM.2008.006.
102. Petersen SE, Matthews PM, Bamberg F, et al. Imaging in population science: cardiovascular magnetic resonance in 100,000 participants of UK Biobank-rationale, challenges and approaches. J Cardiovasc Magn Reson. 2013;15:46. doi: 10.1186/1532-429X-15-46.
103. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117-171.
104. Seely EW, Rich-Edwards J, Lui J, Nicklas JM, Saxena A, Tsigas E, Levkoff SE. Risk of future cardiovascular disease in women with prior preeclampsia: a focus group study. BMC Pregnancy Childbirth. 2013;13:240. doi: 10.1186/1471-2393-13-240.
105. Young B, Hacker MR, Rana S. Physicians' knowledge of future vascular disease in women with preeclampsia. Hypertens Pregnancy. 2012;31:50-58. doi: 10.3109/10641955.2010.544955.
106. Visintin C, Mugglestone MA, Almerie MQ, Nherera LM, James D, Walkinshaw S; Guideline Development Group. Management of hypertensive disorders during pregnancy: summary of NICE guidance. BMJ. 2010;341:c2207.